CS-526 is a potent, competitive, reversible, and orally active acid pump antagonist that inhibits H⁺,K⁺-ATPase activity, suppresses gastric acid secretion, prevents esophageal lesions, and shows potential for the study of gastroesophageal reflux disease (GERD).